Announcements Trials

Browse Landscape

Phase

Phase NA 21 Phase 2 15 Phase 1 15 Phase 1/2 7 Phase 3 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 26 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Prostatic Neoplasms 8 Multiple Myeloma 8 Lung Neoplasms 7 Melanoma 5 Leukemia, Myeloid, Acute 5 Neoplasm Metastasis 4 Glioma 4 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Tuberous Sclerosis 3 Stomach Neoplasms 3 Sarcoma 3 Papillomavirus Infections 3 Leiomyoma 3 Hematologic Neoplasms 3 Glioblastoma 3 Carcinoma, Renal Cell 3 Venous Thromboembolism 2 Rectal Neoplasms 2 Polycythemia Vera 2 Pain 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Obesity 2 Neoplasms by Site 2 Myasthenia Gravis 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Liver Neoplasms × 90 days × Clear all

NCT03151213 2026-03-13

pregabalin

Tanta University

Phase 4 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡